- €11.75m
- €33.66m
- €57.85m
- 39
- 66
- 51
- 50
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.11 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 3.05 | ||
| Price to Sales | 0.21 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -33.33% | ||
| Return on Equity | -90.34% | ||
| Operating Margin | -12.59% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 42.78 | 48.37 | 57.84 | 56.96 | 57.85 | 59.08 | 63.64 | 7.84% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -47.51 | +234.49 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Labiana Health SA is a Spain-based holding company involved in the pharmaceuticals sector. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- December 28th, 2017
- Public Since
- June 24th, 2022
- No. of Employees
- 413
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Madrid Stock Exchange- Shares in Issue
- 7,120,578
- Address
- AV. EUROPA, 34 D 1a PLANTA, POZUELO DE ALARCON, 28023
- Web
- https://www.labiana.com/
- Phone
- Contact
- Cristina Ramos Recoder
- Auditors
- BDO Auditores, S.L.
Upcoming Events for LAB
Similar to LAB
1nkemia IUCT SA
Madrid Stock Exchange
Almirall SA
Madrid Stock Exchange
Faes Farma SA
Madrid Stock Exchange
Grifols SA
Madrid Stock Exchange
Laboratorio Reig Jofre SA
Madrid Stock Exchange
FAQ
As of Today at 19:12 UTC, shares in Labiana Health SA are trading at €1.65. This share price information is delayed by 15 minutes.
Shares in Labiana Health SA last closed at €1.65 and the price had moved by -47.45% over the past 365 days. In terms of relative price strength the Labiana Health SA share price has underperformed the FTSE Global All Cap Index by -51.53% over the past year.
The overall consensus recommendation for Labiana Health SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Labiana Health SA does not currently pay a dividend.
Labiana Health SA does not currently pay a dividend.
Labiana Health SA does not currently pay a dividend.
To buy shares in Labiana Health SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €1.65, shares in Labiana Health SA had a market capitalisation of €11.75m.
Here are the trading details for Labiana Health SA:
- Country of listing: Spain
- Exchange: MCE
- Ticker Symbol: LAB
Based on an overall assessment of its quality, value and momentum Labiana Health SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Labiana Health SA is €3.30. That is 100% above the last closing price of €1.65.
Analysts covering Labiana Health SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.19 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Labiana Health SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +33.99%.
As of the last closing price of €1.65, shares in Labiana Health SA were trading +6.64% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Labiana Health SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Labiana Health SA's directors